[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Metsera, Inc. Common Stock (MTSR)
Pfizer acquires Metsera for $XXX billion, sending MTSR shares soaring. The deal gives Pfizer a foothold in the booming obesity treatment market.
About Metsera, Inc. Common Stock
Metsera, Inc. Common Stock (MTSR) is a stock of a company focused on developing protein drugs for obesity treatment.
Metsera, Inc. Common Stock uses the ticker $MTSR for trading. Listed in the Stocks and category.
Insights #
- Metsera, Inc. Common Stock (MTSR) social dominance is up XXX% from the previous month.
- Metsera, Inc. Common Stock (MTSR) sentiment is up XXXXX% from the previous week.
Price: $XXXXX #
Price 24-Hour Time-Series Raw Data
The price action is likely driven by the Pfizer acquisition news, with the stock price hitting a 52-week high. The positive sentiment from the acquisition and the potential of Metsera's pipeline are likely contributing to the price increase.
| 24-Hour | 7-Day | 30-Day |
|---|---|---|
| XXXX% | -XXXX% | XXXXX% |
1-Year High: $XXXXX on 2025-09-22
1-Year Low: $XXXXX on 2025-04-10
AltRank: XXXXX #
AltRank 24-Hour Time-Series Raw Data
Metsera, Inc. Common Stock (MTSR) is currently AltRank #1,331 based on combined combined social and market metrics
Daily Average: XXXXX
1 Week: XXX +261
1 Month: XXXXX +74
6 Months: XXXXX +1,234
1 Year: XXXXX -XXX
1-Year High: XXXXX on 2025-07-28
1-Year Low: XX on 2025-09-22
Galaxy Score: XXXXX #
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX -XX
1 Month: XX -XX
6 Months: XX -XX
1 Year: XX +21
1-Year High: XX on 2025-09-22
1-Year Low: XX on 2025-05-09
Engagements: XXXXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXXXXX +314%
6 Months: XXXXXXXXX +376%
1 Year: XXXXXXXXX +306%
1-Year High: XXXXXXX on 2025-09-22
1-Year Low: X on 2024-10-26
| Social Network | X | YouTube |
|---|---|---|
| Engagements | XXXXX | X |
Mentions: XX #
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1 Month: XXXXX +244%
6 Months: XXXXX +831%
1 Year: XXXXX +14,137%
1-Year High: XXXXX on 2025-09-23
1-Year Low: X on 2024-10-26
| Social Network | X | YouTube |
|---|---|---|
| Mentions | XX | X |
Creators: XX #
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Metsera, Inc. Common Stock (MTSR) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
1 Month: XXX +260%
6 Months: XXXXX +1,190%
1 Year: XXXXX +9,805%
1-Year High: XXXXX on 2025-09-23
1-Year Low: X on 2024-10-22
The most influential creators that mention Metsera, Inc. Common Stock in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @bioinvestor24 | X | XXXXX | XX | XXXXX |
| @MeadowCapital | X | XXXXX | X | XXX |
| @ResearchPulse1 | X | XXXXX | X | XXX |
| @doepke_michel | X | XXXXX | X | XXX |
| @PersimmonTI | X | XXXXXX | X | XX |
| @Biotech2k1 | X | XXXXXX | X | XX |
| @JoseRestonVA | X | XXXXX | X | XX |
| @themarketuni | X | XXXXX | X | XX |
| @BiopharmIQ | X | XXXXXX | X | XX |
| @MarketCap_Live | XX | XXX | X | XX |
Sentiment: XX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% +14%
1 Month: XX% no change
6 Months: XX% -X%
1 Year: XX% -XX%
1-Year High: XXX% on 2024-11-20
1-Year Low: XX% on 2025-01-13
Most Supportive Themes
- Pfizer Acquisition: (55%) Pfizer's acquisition of Metsera is viewed as a major positive, injecting capital and resources into the company's obesity drug pipeline.
- Positive Data and Pipeline: (25%) The potential of Metsera's lead drug and other molecules in the clinic, along with the company's innovative technology, are highlighted as key strengths.
- Market Opportunity: (10%) The booming obesity treatment market and the potential for Metsera to capture a significant share are driving positive sentiment.
Most Critical Themes
- Valuation Concerns: (5%) Some investors question whether the acquisition price is justified, especially compared to the valuations of other companies in the space.
- Competition: (5%) The competitive landscape in the obesity drug market, with established players like Eli Lilly and Novo Nordisk, poses a challenge.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXX | XX% | XXXXX | XX% | XX | X% |
| YouTube | X | X% | X | X% | X | X% |
| Total | XXX | XX% | XXXXX | XX% | XX | X% |
Social Dominance: XXXXXXX% #
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
1 Week: XXXX% +0.0028%
1 Month: XXXXXXX% +0.00416%
6 Months: XXXXXXX% -XXXXX%
1 Year: XXXXXXX% +0.00686%
1-Year High: XXXXX% on 2025-09-23
1-Year Low: XXXXXX% on 2024-12-07
Market Dominance: XXXXXXX% #
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-31
1-Year Low: XXXXXXX% on 2025-04-10
Market Cap: $XXXXXXXXXXXXX #
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX -$0.45%
1 Month: $XXXXXXXXXXXXX +$54%
6 Months: $XXXXXXXXXXXXX +$170%
1-Year High: $XXXXXXXXXXXXX on 2025-09-22
1-Year Low: $XXXXXXXXXXXXX on 2025-04-10
Top assets mentioned In the posts about Metsera, Inc. Common Stock in the last XX hours
Pfizer, Inc. (PFE) Viking Therapeutics, Inc (VKTX) Novo-Nordisk (NVO) Eli Lilly and Company (LLY) Bitcoin Incognito (XBI) Akropolis (AKRO) Merus N.V. Common Shares (MRUS) AbbVie Inc (ABBV) IDEAYA Biosciences, Inc. Common Stock (IDYA)
Top topics mentioned In the posts about Metsera, Inc. Common Stock in the last XX hours
stocks healthcare, $pfe, $vktx, $nvo, eli lilly, stocks bitcoin treasuries, $xbi, acquisition, stocks technology, $akro, $mrus, $etnb, $gpcr, $abbv, $idya, coins solana ecosystem, has been, $rna, $apge, $psnl, advanced micro devices, agnico eagle, stocks basic materials, $lly, $mdgl, $trml, $kymr, $200m2b, stocks bitcoin miners, $qmmm, $vrna, $bpmc, $ssrm, $zeal, stocks consumer defensive, investment, $hrow, $sndx, $angi, $arbe, united therapeutics corp, $uthr, $mltx, $amgn, $mrk, $orka, $wve, $beam, china, $bntx, $bny, $smmt, coins base ecosystem, coins arbitrum, zillow group inc, stocks communication services, $zg, $uec, $wor, $nvda, cvs, $16b, $frsh, $asts, $rvmd, stocks crypto treasuries, stocks financial services, bain capital, $vor, $gdxd, $bhf, $swtx, autocrypto, coins bsc, coins ai, $au, $rhhby, $quremy, $paas, $qure, $pro, $bkkt, $bfb, $csan, $qubt, $mens, bitmine, $spy, $qqq, $iwm, meadow, $20s, $ions, $bbio, $amg, money, $axsm, $nuvl, dexcom inc, $dxcm
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Kailera is not for sale now. They know they own the right mechanism and a drug that is very close to best selling drug in history from $LLy so they will not sell for $XX B or give out their company for cheap like $MTSR did. Metsera management knew they had bad data and nothing competitive with Lilly long term and thus sold the company. Kailera management is acting differently"
X Link @bioinvestor24 2025-10-14T21:26Z 4374 followers, XXX engagements
"$vktx $nvo $lly $pfe Obesity: Kailera raised $600M in series B (Kailera licensed GLP from its parent company Hengrui for $6B) $mtsr Metsera got bought at $7.3B $mrk Hansoh preclinical deal at $2B $AZN Eccogene's deal at $2B $RHHBY Roche bought Carmot at $2.7B Roche partnered with Zealand for $5.6B MASH: $akro Akero bought at $5.2B $etnb 89bio bought at $3.5B Boston pharma bought at $2B"
X Link @cloud_walker200 2025-10-14T13:46Z XXX followers, 1182 engagements
"Kailera was/is my candidate for next obesity BO. With todays pipe the price just went up"
X Link @ResearchPulse1 2025-10-14T13:44Z 1480 followers, 1459 engagements
"Kailera Therapeutics Announces $XXX Million Series B Financing to Further Advance Pipeline of Next-Generation Therapies for the Treatment of Obesity. $NVO $LLY $VKTX $MTSR"
X Link @doepke_michel 2025-10-14T10:33Z 5572 followers, 5614 engagements